Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 230

    Aurobindo to acquire Sandoz US dermatology, oral solids business for about Rs 6,470 crore CASH

    Aurobindo to acquire Sandoz US dermatology, oral solids business for about Rs 6,470 crore CASH

    Ruby Khatun Khatun7 Sept 2018 12:44 PM IST
    Overall the transaction will position Aurobindo as the 2nd largest dermatology player and the 2nd largest generics company in the US by prescriptions,...
    NCLT issues notices to Malvinder, Godhvani; directs status quo over RHC Holdings

    NCLT issues notices to Malvinder, Godhvani; directs status quo over RHC Holdings

    Ruby Khatun Khatun7 Sept 2018 10:30 AM IST
    New Delhi: The National Company Law Tribunal (NCLT) on Thursday issued notices to Malvinder Mohan Singh, ex-Religare chief Sunil Godhwani and others,...
    Lupin to train over 1,000 graduates for pharma industry

    Lupin to train over 1,000 graduates for pharma industry

    Medical Dialogues Bureau7 Sept 2018 10:15 AM IST
    New Delhi: Pharmaceutical giant, Lupin Limited expects to train more than 1,000 undergraduates into pharma professionals by the year 2020 under its...
    FDA extends review of Roches Tecentriq by three months

    FDA extends review of Roche's Tecentriq by three months

    Medical Dialogues Bureau7 Sept 2018 10:00 AM IST
    ZURICH: Roche said the U.S. Food and Drug Administration (FDA) had extended by three months the review period for Tecentriq in combination therapy as...
    Insurance tactic drags down US drug prices in second quarter: analyst

    Insurance tactic drags down US drug prices in second quarter: analyst

    Ruby Khatun Khatun7 Sept 2018 9:45 AM IST
    NEW YORK: U.S. drug prices fell again in the second quarter, likely due to new tactic insurers are using to limit financial assistance drugmakers...
    Sanofi to pay more than 25 million dollar to resolve corruption charges: SEC

    Sanofi to pay more than 25 million dollar to resolve corruption charges: SEC

    Ruby Khatun Khatun7 Sept 2018 9:30 AM IST
    WASHINGTON: French pharmaceutical giant Sanofi will pay more than $25 million to settle charges that its Kazakhstan and the Middle East subsidiaries...
    Family feud: Shivinder accuses Malvinder of forging wifes signature

    Family feud: Shivinder accuses Malvinder of forging wife's signature

    Ruby Khatun Khatun6 Sept 2018 12:14 PM IST
    New Delhi: Former Fortis Healthcare promoter Shivinder Mohan Singh has alleged that his elder brother Malvinder forged his wife's signature,...
    Zydus Cadila gets USFDA approval for antiviral drug

    Zydus Cadila gets USFDA approval for antiviral drug

    Ruby Khatun Khatun6 Sept 2018 10:44 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Acyclovir injection, used to treat...
    Immense scope for medical tourism between India, Netherlands: Ayush Minister

    Immense scope for medical tourism between India, Netherlands: Ayush Minister

    Ruby Khatun Khatun6 Sept 2018 10:00 AM IST
    The Hague: There is an immense scope for cooperation in medical tourism between India and the Netherlands, Union Minister of State for Ayush Shripad...
    ProQR drug for rare childhood blindness succeeds in early trial

    ProQR drug for rare childhood blindness succeeds in early trial

    Ruby Khatun Khatun6 Sept 2018 9:45 AM IST
    Dutch drug developer ProQR Therapeutics NV said its interim analysis showed that an early-stage trial of an experimental treatment for a rare form of...
    UK deal makes Novartis cancer cell therapy available to kids

    UK deal makes Novartis cancer cell therapy available to kids

    Ruby Khatun Khatun6 Sept 2018 9:30 AM IST
    LONDON: Health authorities in England have agreed with Swiss drugmaker Novartis to fast-track access to its expensive CAR-T cell therapy Kymriah and...
    JnJ Faulty Hip Implants: Another Expert panel formed to determine compensation to patients

    JnJ Faulty Hip Implants: Another Expert panel formed to determine compensation to patients

    Ruby Khatun Khatun5 Sept 2018 12:39 PM IST
    New Delhi: The Centre has constituted a five-member expert committee to determine the quantum of compensation to be given to patients who have...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok